Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery
Journal of Surgical Oncology2014Vol. 110(7), pp. 817–822
Citations Over TimeTop 10% of 2014 papers
Elizabeth Pan, Saveli Goldberg, Yen‐Lin Chen, Christine Giraud, Jason L. Hornick, G. Petur Nielsen, Francis J. Hornicek, Chandrajit P. Raut, Thomas F. DeLaney, Elizabeth H. Baldini
Abstract
We did not identify a LC advantage for an RT boost. Given the unidentified selection factors for delivery of boost and its potential toxicities, its role in this setting remains unproven.
Related Papers
- → The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.(1999)7 cited
- The role of brachytherapy in the 21st century for prostate cancer.(2010)
- Preliminary Study of Permanent ~(103)Pd Radioactive Seed Implantation on Maligmant Tumor in Brachytherapy(2001)
- → From Point A to MRI-Guided Brachytherapy in Cancer Cervix: Rationalizing Brachytherapy Practice in India(2019)
- → Salvage Brachytherapy after Primary Brachytherapy in Recurrent Prostate Cancer(2020)